UPR pathway modulators (Proteostasis)

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameUPR pathway modulators (Proteostasis)

Drug Alias NameUnfolded protein response pathway modulators (Proteostasis)endogenous proteostasis network pathway receptor modulators (Proteostasis Therapeutics)

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionAlpha-1-antiproteinase modulators

TargetsAlpha-1-antiproteinase

Therapy Area/IndicationsNerve DegenerationCystic Fibrosisalpha 1-Antitrypsin Deficiency

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesProteostasis Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesProteostasis Therapeutics Inc

Active IndicationsN/A

Inactive IndicationsNerve DegenerationCystic Fibrosisalpha 1-Antitrypsin Deficiency

Other Information

ATC CodeN/A